Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Akoya Biosciences Inc (NASDAQ: AKYA) closed at $2.41 down -23.00% from its previous closing price of $3.13. In other words, the price has decreased by -$23.00 from its previous closing price. On the day, 1.26 million shares were traded. AKYA stock price reached its highest trading level at $2.55 during the session, while it also had its lowest trading level at $2.08.
Ratios:
For a deeper understanding of Akoya Biosciences Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.85 and its Current Ratio is at 2.75. In the meantime, Its Debt-to-Equity ratio is 6.23 whereas as Long-Term Debt/Eq ratio is at 5.96.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Craig Hallum on November 15, 2024, Downgraded its rating to Hold and sets its target price to $5 from $7 previously.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 11 ’24 when McKelligon Brian sold 7,500 shares for $2.08 per share. The transaction valued at 15,630 led to the insider holds 224,733 shares of the business.
McKelligon Brian sold 7,500 shares of AKYA for $15,064 on Jun 06 ’24. The President and CEO now owns 224,733 shares after completing the transaction at $2.01 per share. On Mar 20 ’24, another insider, McKelligon Brian, who serves as the President and CEO of the company, sold 7,500 shares for $4.97 each. As a result, the insider received 37,243 and left with 231,868 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AKYA now has a Market Capitalization of 119293800 and an Enterprise Value of 194407392. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.06 while its Price-to-Book (P/B) ratio in mrq is 8.75. Its current Enterprise Value per Revenue stands at 2.086 whereas that against EBITDA is -4.923.
Stock Price History:
Over the past 52 weeks, AKYA has reached a high of $6.31, while it has fallen to a 52-week low of $1.88. The 50-Day Moving Average of the stock is -17.09%, while the 200-Day Moving Average is calculated to be -27.65%.
Shares Statistics:
For the past three months, AKYA has traded an average of 127.49K shares per day and 241110 over the past ten days. A total of 49.12M shares are outstanding, with a floating share count of 20.55M. Insiders hold about 58.55% of the company’s shares, while institutions hold 24.54% stake in the company. Shares short for AKYA as of 1730332800 were 1601700 with a Short Ratio of 12.56, compared to 1727654400 on 2355998. Therefore, it implies a Short% of Shares Outstanding of 1601700 and a Short% of Float of 5.3400002.
